MedPath

DARUPH 55 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

DARUPH 55 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

Pending
Register Number

89524

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Jun 28, 2024

Dosage Form

COMPRIMIDO RECUBIERTO CON PELÍCULA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number89524
EMA Approved
No

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
No
CIMA AEMPS Classification

INGREDIENTS (1)

DASATINIBActive
Quantity: 55,3 mg
Name: DASATINIB

ATC CLASSIFICATION (3)

L01E
L01EA
L01EA02

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.